Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.88
-0.19 (-3.13%)
At close: Jul 10, 2026, 4:00 PM EDT
6.00
+0.12 (2.04%)
After-hours: Jul 10, 2026, 7:44 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $2.91 billion as of July 10, 2026. Its market cap has decreased by -72.89% in one year.
Market Cap
2.91B
Enterprise Value
2.91B
1-Year Change
-72.89%
Ranking
Category
Stock Price
$5.88
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $2.91B, an increase of 2,325.80%. That is a compound annual growth rate of 89.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.91B | -71.94% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 5.41B |
| Indivior Pharmaceuticals | 4.99B |
| Kiniksa Pharmaceuticals International, | 4.98B |
| Supernus Pharmaceuticals | 2.93B |
| BioCryst Pharmaceuticals | 2.82B |
| Prestige Consumer Healthcare | 2.31B |
| Amylyx Pharmaceuticals | 1.96B |
| HUTCHMED (China) | 1.96B |